Abstract
Because binding of antiphospholipid antibody (aPL) to phosphatidylethanolamine (PE) is central to the definition of the antigenic epitope targeted by aPLs, we examined the binding of aPL-positive SLE sera to PE under various conditions. No serum bound to PE uncontaminated with lysophosphatidylethanolamine (IPE), but many aPL-positive sera bound to IPE-contaminated PE and to IPE coated onto an ELISA plate. Absorption studies indicated partial cross-reactivity between PE containing IPE and cardiolipin. We conclude that clinical aPLs do not bind to PE. Prior reports to the contrary most likely represent binding of aPL to PE's degradation product, IPE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Harris EN, Gharavi AE, Hughes GRV: Anti-phospholipid antibodies. Clin Rheum Dis 11:591–609, 1985
Harris EN, Gharavi AE, Loizou S, Derue G, Chan JKH, Patel BM, Mackworth-Young CG, Bunn CC, Hughes GRV: Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 16:1–6, 1985
Harris EN, Gharavi AE, Patel SP, Hughes GRV: Evaluation of the anticardiolipin antibody test: Report of an international workshop held April 4, 1986. Clin Exp Immunol 68:738–745, 1987
Gharavi AE, Harris EN, Asherson RA, Hughes GRV: Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 46:1–6, 1987
Rauch J, Tannenbaum M, Tannenbaum H, Ramelson H, Cullis PR, Tilcock CPS, Hope MJ, Janoff AS: Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem 261:9672–9677, 1986
Harris EN, Gharavi AE, Wasley GD, Hughes GRV: Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis 157:23–31, 1988
Colaco CB, Male DK: Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: Distinct profiles of epitope specificity. Clin Exp Immunol 59:449–456, 1985
Staub HL, Harris EN, Khamashta MA, Savidge G, Chahade WH, Hughes GRV: Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thromboses. Ann Rheum Dis 48:166–169, 1989
Qamar T, Levy RA, Sammaritano L, Gharavi AE, Lockshin MD: Characteristics of high-titer IgG antiphospholipid antibody (aPL) in systemic lupus erythematosus patients with and without fetal death. Arth Rheum 33:501–504, 1990
Gharavi AE, Lockshin MD: Enhancement of antiphospholipid activity by Tween 20. J Immunol Methods 114:277, 1988 (corresp)
Cowchock S, Fort J, Munoz S, Norberg R, Maddrey W: False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortions, rheumatologic disorders, and primary biliary cirrhosis: Correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol 73:289–294, 1988
Lockshin MD, Qamar T, Levy RA, Best MP: IgG but not IgM antiphospholipid antibody binding is temperature dependent. J Clin Immunol 8:188–192, 1988
Lockshin MD: Anticardiolipin antibody. Arch Rheum 30:471–472, 1987
Ranier S, Jain MK, Ramirez F, Ioannou P, Marecek JF, Wagner R: Phase transition characteristics of diphosphatidylglycerol (cardiolipin) and stereoisomeric phosphatidylglycerol bilayers. Biochim Biophys Acta 558:187–198, 1979
Touchstone JC, Levin SS, Dobbins MF, Carter PJ: Differentiation of saturated and unsaturated phospholipids on thin layer chromatograms. J High Res Chromatogr Chromatogr Comm 4:423–424, 1981
Koike T, Sueishi M, Funaki H, Tomioka H, Yoshida S: Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984;56:193–199
Levy RA, Gharavi AE, Sammaritano LR, Habina LM, Lockshin MD: Fatty acid chain is a critical epitope for antiphospholipid antibody. J Clin Immunol 10:141–145, 1990
Levy RA, Gharavi AE, Sammaritano LR, Habina LM, Qamar T, Lockshin M: IgG antiphospholipid antibodies of patients with SLE and with syphilis differ. J Rheumatol 1990 (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Qamar, T., Gharavi, A.E., Levy, R.A. et al. Lysophosphatidylethanolamine is the antigen to which apparent antibody to phosphatidylethanolamine binds. J Clin Immunol 10, 200–203 (1990). https://doi.org/10.1007/BF00918652
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918652